DTC
NUVB icon

Deep Track Capital’s Nuvation Bio NUVB Stock Holding History

Deep Track Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,720,688
Closed -$10.3M – 72
2023
Q3 		$10.3M Hold
7,720,688
– – 0.4% 50
2023
Q2 		$13.9M Hold
7,720,688
– – 0.64% 37
2023
Q1 		$12.8M Sell
7,720,688
-500,500
-6% -$1.01M 0.53% 44
2022
Q4 		$15.8M Sell
8,221,188
-1,104,352
-12% -$2.23M 0.66% 43
2022
Q3 		$20.9M Sell
9,325,540
-2,145,741
-19% -$6.13M 0.96% 39
2022
Q2 		$37.2M Buy
11,471,281
+10,315,789
+893% +$45M 2.44% 17
2022
Q1 		$6.08M Buy
+1,155,492
New +$6.49M 0.39% 43

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deep Track Capital's NUVB Position: Q4 2023 in Review

Deep Track Capital sold out of Nuvation Bio (NUVB) in Q4 2023, closing a stake of 7,720,688 shares — an estimated $10.3M sold.

Deep Track Capital first reported a position in NUVB in Q1 2022 and held it in 7 quarters. The position peaked at $37.2M in Q2 2022. 116 funds tracked by Wall St. Rank hold NUVB as of Q4 2023.

  • Deep Track Capital reported no remaining Nuvation Bio position as of Q4 2023 after selling out during the quarter.
  • Deep Track Capital sold 7,720,688 Nuvation Bio shares in Q4 2023, an estimated $10.3M.
  • Deep Track Capital first reported a position in Nuvation Bio in Q1 2022 and held it in 7 quarters.
  • Deep Track Capital's Nuvation Bio position peaked at $37.2M in Q2 2022.
  • 116 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2023.

Based on Deep Track Capital's 13F filing for Q4 2023, filed 14 Feb 2024.